Center Care (Meritain) policies, page 20

Search Center Care (Meritain)'s public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Center Care (Meritain), by title.

Center Care (Meritain) policies
PolicyDetailsCodesSource
[Pharmacy] Brexafemme ST with Limit, Post PA Policy 4778-E 01-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4778-E · Commercial—Original policy ↗
[Pharmacy] Brexafemme ST with Limit, Post PA Policy 4778-E 01-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4778-E · Commercial—Original policy ↗
[Pharmacy] Brexafemme ST with Limit, Post PA Policy 4778-E UDR 01-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4778-E · Commercial—Original policy ↗
[Pharmacy] Brisdelle PA with Limit Policy 2926-C 01-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2926-C · Commercial—Original policy ↗
[Pharmacy] Brisdelle PA with Limit Policy 2926-C 01-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2926-C · Commercial—Original policy ↗
[Pharmacy] Brisdelle PA with Limit Policy 2926-C 01-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2926-C · Commercial—Original policy ↗
[Pharmacy] Brisdelle PA with Limit Policy 2926-C 01-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2926-C · Commercial—Original policy ↗
[Pharmacy] Brisdelle PA with Limit Policy 2926-C 06-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2926-C · Commercial—Original policy ↗
[Pharmacy] Briviact PA Policy 1337-A 06-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1337-A · Commercial—Original policy ↗
[Pharmacy] Briviact PA Policy 1337-A UDR 06-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1337-A · Commercial—Original policy ↗
[Pharmacy] Briviact PA Policy 1337-A UDR 06-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1337-A · Commercial—Original policy ↗
[Pharmacy] Brukinsa 3411-A SGM P2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan3411-A · Commercial—Original policy ↗
[Pharmacy] Brukinsa 3411-A SGM P2022a - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan3411-A SGM P2022a · Commercial—Original policy ↗
[Pharmacy] Brukinsa 3411-A SGM P2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan3411-A · Commercial—Original policy ↗
[Pharmacy] Brukinsa 3411-A SGM P2023b - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan3411-A · Commercial—Original policy ↗
[Pharmacy] Brukinsa 3411-A SGM P2023b - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan3411-A · Commercial—Original policy ↗
[Pharmacy] Brukinsa SGM 3411-A P2024a_R - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan3411-A · Commercial—Original policy ↗
[Pharmacy] Brukinsa SGM 3411-A P2024a_R - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan3411-A · Commercial—Original policy ↗
[Pharmacy] Buprenorphine Limit Policy 2897-H 12-2021 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2897-H · Commercial—Original policy ↗
[Pharmacy] Buprenorphine Limit Policy 2897-H 12-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2897-H · Commercial—Original policy ↗
[Pharmacy] Buprenorphine Limit Policy 2897-H 12-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2897-H · Commercial—Original policy ↗
[Pharmacy] Buprenorphine Limit Policy 2897-H 12-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2897-H · Commercial—Original policy ↗
[Pharmacy] Buprenorphine Limit Policy 2897-H 12-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2897-H · Commercial—Original policy ↗
[Pharmacy] Buprenorphine Limit, Post PA 2328-HJ P12-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2328-HJ · Commercial—Original policy ↗
[Pharmacy] Buprenorphine-Naloxone Limit 1553-H 12-2021 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1553-H · Commercial—Original policy ↗
[Pharmacy] Buprenorphine-Naloxone Limit 1553-H P12-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1553-H P12-2024 · Commercial—Original policy ↗
[Pharmacy] Buprenorphine-Naloxone Limit 1553-H P12-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1553-H P12-2024 · Commercial—Original policy ↗
[Pharmacy] Buprenorphine-Naloxone Limit Policy 1553-H 12-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1553-H · Commercial—Original policy ↗
[Pharmacy] Buprenorphine-Naloxone Limit Policy 1553-H 12-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1553-H · Commercial—Original policy ↗
[Pharmacy] Butalbital Products Limit 38-H 07-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan38-H · Commercial—Original policy ↗
[Pharmacy] Butalbital Products Limit 38-H P06-2024_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan38-H P06-2024_R · Commercial—Original policy ↗
[Pharmacy] Butalbital Products Limit 38-H P06-2024_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan38-H P06-2024_R · Commercial—Original policy ↗
[Pharmacy] Butalbital Products Limit 38-H P06-2024_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan38-H P06-2024_R · Commercial—Original policy ↗
[Pharmacy] Butalbital Products Limit Policy 38-H 06-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan38-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Limit 212-H 07-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Limit 212-H 07-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Limit 212-H P06-2024_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Limit 212-H P06-2024_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Limit 212-H P06-2024_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Limit Policy 212-H 06-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Limit Policy 212-H 06-2023 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Post Limit PA Policy 213-J 07-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan213-J · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution (Stadol) Post Limit PA Policy 213-J 07-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan213-J · Commercial—Original policy ↗
[Pharmacy] Butorphanol Nasal Solution Limit 212-H P06-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan212-H · Commercial—Original policy ↗
[Pharmacy] Cablivi 2871-A SGM P2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2871-A · Commercial—Original policy ↗
[Pharmacy] Cablivi 2871-A SGM P2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2871-A · Commercial—Original policy ↗
[Pharmacy] Cablivi 2871-A SGM P2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2871-A · Commercial—Original policy ↗
[Pharmacy] Cablivi 2871-A SGM P2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2871-A · Commercial—Original policy ↗
[Pharmacy] Cabometyx 2212-A SGM P2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2212-A · Commercial—Original policy ↗
[Pharmacy] Cabometyx 2212-A SGM P2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2212-A · Commercial—Original policy ↗

Back to Center Care (Meritain)

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.